A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis

Abroad (travel likely)RecruitingPHASE2

Conditions

MF,PMF,PPV-MF,PET-MF

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • West China Hospital Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (JingZe Zuo) · huaxilunli@163.com · 028-85422654
  • Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Qirou Wang, Doctor) · ec@ihcams.ac.cn · 022-23909095
Study leads
  • Zhijian Xiao, Doctor

    Principal Investigator

    Hematology Hospital, Chinese Academy of Medical Sciences

  • Ting Niu, Doctor

    Principal Investigator

    West China Hospital